Transcript
Page 1: BIOCON-CO2: from carbon dioxide to valuable chemicals · to BIOCON-CO2 Ethanol CO 2 Lactate Pyruvate Acetaldehyde NAD+ NADH ADH LDH PDC High resolution structure The aims of BIOCON-CO2:

Selected pool of stabilising

mutants

Primers design and

mutagenesis

Expression in small scale

Stabilisation screening by Thermofluor

Combination of positive mutants

Simulation of wild type with

inhibitors

Rational mutagenesis

based on trajectories

Simulation of mutants with

inhibitors

To further increase the concentration of CO2 in solution, weconvert it to bicarbonate using carbonic anhydrase.

BIOCON-CO2: from carbon dioxide to valuable chemicals

Enzymatic CO2 solubilisation

FRESCO pipeline

FoldXRosetta

ddg

Molecular

dynamics

Visual inspection of predicted mutants

Experimental verification of mutants

Simone Savino, Hein J. Wijma, Marco W. Fraaije

Enzymatic CO2

solubilisation

Biocatalysts stabilisation

RUG contributionto BIOCON-CO2

Ethanol

CO2

Lactate Pyruvate

Acetaldehyde

NADHNAD+

ADH

LDH

PDC

High resolution structure

The aims of BIOCON-CO2:

• reduce the emissions of CO2 coming from industrial production

• exploit the carbon source to produce high value compounds

Biocatalysts stabilisation

The FRESCO protocol

is composed of in silico

and in vitro evaluation

steps. In this way the

number of variants to

be tested at the bench

is reduced while

remaining significant.

PDC: mutants selection in silico

ADH: recombinant expression of mutants

LDH: testing mutants thermoresistance

In the first FRESCO step, the

crystallographic structure is checked

and adapted for the following energy

calculations, disulphide bonds

discovery and molecular dynamics

simulations. After this, a reasonable

pool of mutants is proposed to the

operator, who checks them on the

screen and selects the promising

ones according to criteria such as:

loss or gain of H bonds,

hydrophobicity and flexibility of the

side chains. In PDC case the

mutants to be screened were 1200.

Target enzyme: human carbonic anhydrase II

hCAIICO

2 + H2O HCO

3- + H+

Industry CO2

Suppliers

Biotech Industry

Public and

Private Investors

Local Authorities/Decisi

on Makers

Regulators/Policy Makers

Chemical/ Food / Plastic

Industries

Scientific Communi

ty

Related H2020

Initiatives

General Public

Our partners Our targets

Tackle inhibition from contaminants

Increase protein stability

As further described in this poster, we are applying the FRESCOprotocol to carbonic anhydrase, in order to make the enzymemore resistant to the conditions in which its reaction will berequired. Such measure is required to make the enzyme lastlonger, in this way making the process cheaper and efficient.

Contaminants are present in heavy industry off-gases, whichbehave as inhibitors of the enzyme. To decrease the affinity ofthese small molecules for carbonic anhydrase, we performmolecular dynamics and design mutants.

Here we present the different advancement stages of the

process for the enzymes that are part of our project.

Once the number of selected mutants has been reduced,

mutagenesis primers are ordered and the mutants are

expressed in small scale, typically in 96-wells plates. For

ADH, visual inspection suggested 93 mutants to be

expressed.

Expressed proteins are purified and their melting

temperature determined by Thermofluor or ThermoFAD

assay. By comparing with wild type enzyme, a number of

variants is selected and mutations can be combined to

create a super-resistant version of the enzyme.

63 63 65 65 66 66 66 67 67 68 69 7160

62

64

66

68

70

72

Tm

Thermofluor +20% EtOH

In the LDH case, 71 variants were selected, expressed in

E.coli and purified. Because of the high Tm of the wild type

enzyme (95°C), 20% ethanol was added to the mixture for

the Thermofluor assay, in this way destabilising the

samples in the same way.Also, since ethanol will

be present in the final

reaction, this values

reflect the actual stability

of the enzyme in the

solvent-rich environment.

Top Related